Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis-Reference-Cited by-同舟云学术

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

Published:2016-12-13 Issue:12 Volume:13 Page:e1002193
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Jiang Tingting,Shi Weiwei,Wali Vikram B.,Pongor Lőrinc S.,Li Charles,Lau Rosanna,Győrffy Balázs,Lifton Richard P.,Symmans William F.,Pusztai Lajos,Hatzis Christos^ORCID

Funder

Breast Cancer Research Foundation

Lion Heart Fund for Cancer Research

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference58 articles.

1. Triple-negative breast cancer;WD Foulkes;N Engl J Med,2010

2. Dissecting the heterogeneity of triple-negative breast cancer;O Metzger-Filho;J Clin Oncol,2012

3. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;C Liedtke;J Clin Oncol,2008

4. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;P Cortazar;Lancet,2014

5. Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple-negative breast cancer;C Hatzis;Clin Cancer Res,2016

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Prognostic Risk Signature of Two Autophagy-Related Genes for Predicting Triple-Negative Breast Cancer Outcomes;Breast Cancer: Targets and Therapy;2024-09

2. Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause;Breast Cancer Research and Treatment;2024-05-08

3. Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry;Frontiers in Immunology;2024-04-22

4. Subtype-Specific Survival of Young Women with Breast Cancer and Its Interaction with the Germline BRCA Status;Cancers;2024-02-10

5. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development;International Review of Cell and Molecular Biology;2024